7-100180567-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 3P and 5B. PM2PP2BP4_StrongBS1_Supporting
The NM_001282717.2(STAG3):c.11C>T(p.Pro4Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000703 in 1,606,964 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001282717.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
STAG3 | NM_001282717.2 | c.11C>T | p.Pro4Leu | missense_variant | 2/34 | ENST00000615138.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
STAG3 | ENST00000615138.5 | c.11C>T | p.Pro4Leu | missense_variant | 2/34 | 1 | NM_001282717.2 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000875 AC: 22AN: 251436Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135898
GnomAD4 exome AF: 0.0000440 AC: 64AN: 1454676Hom.: 0 Cov.: 28 AF XY: 0.0000414 AC XY: 30AN XY: 724258
GnomAD4 genome AF: 0.000322 AC: 49AN: 152288Hom.: 0 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74468
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2022 | The c.11C>T (p.P4L) alteration is located in exon 2 (coding exon 1) of the STAG3 gene. This alteration results from a C to T substitution at nucleotide position 11, causing the proline (P) at amino acid position 4 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2023 | STAG3: PM2, BP4 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at